Thoracic Endovascular Aneurysm Repair (TEVAR) Market Growth Drivers & Forecast 2033

Thoracic Endovascular Aneurysm Repair (TEVAR) by Application (Male Patients, Female Patients), by Types (Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm, Cerebral Aortic Aneurysm, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $2800 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Dec 12, 2025Updated: Jun 8, 2026

Pages: 108

Forecast Period: 2026 - 2033

Market Size: $2800 million

CAGR: 7.5%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

Thoracic Endovascular Aneurysm Repair (TEVAR) Market Overview

Thoracic Endovascular Aneurysm Repair (TEVAR) is a minimally invasive procedure that treats thoracic aortic pathologies by delivering a stent‑graft via catheter. Its clinical relevance stems from reduced peri‑operative morbidity and shorter hospital stays compared with open surgery. The Thoracic Endovascular Aneurysm Repair (TEVAR) market size is projected to reach approximately $3.0 billion in 2025, with a growth outlook driven by an estimated CAGR of 6.5% (2026‑2033). This market forecast reflects accelerating industry expansion across vascular specialties, underpinned by aging demographics, rising incidence of thoracic aortic aneurysms, and expanding reimbursement frameworks.

Loading chart…

Key forces shaping the TEVAR market include technological innovation—notably low‑profile delivery systems and next‑generation graft materials—, evolving regulatory pathways that streamline approvals in major markets, and competitive intensity as legacy device makers and emerging biotech firms vie for market share. The largest market region remains North America, accounting for roughly one‑third of global revenues, while the Asia‑Pacific region is the fastest‑growing segment, propelled by expanding healthcare infrastructure and rising awareness in China and India. These dynamics collectively position TEVAR for robust expansion through 2033, offering strategic opportunities for investors, manufacturers, and healthcare providers alike.

Report Overview

Report Attribute	Details
Market size value in 2025	2.80 billion
Revenue forecast in 2033	4.99 billion
Growth rate	CAGR of 7.5% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Medtronic; Cook Group; W.L. Gore & Associates; Bolton Medical; JOTEC GmbH; Getinge; MicroPort Medical; Terumo; Endologix; Cardinal Health
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Thoracic Endovascular Aneurysm Repair (TEVAR) market is being reshaped by evolving clinical guidelines, reimbursement reforms, and emerging device platforms, creating a dynamic environment that directly influences market size and the near‑term growth forecast.

Growth Drivers2 items

Expanding indications for TEVAR, driven by evidence that endovascular repair reduces peri‑operative mortality in type B aortic dissections, are broadening the eligible patient pool and accelerating the Thoracic Endovascular Aneurysm Repair (TEVAR) market size.

Reimbursement parity in major health systems, especially the inclusion of TEVAR under bundled payment models, improves hospital adoption rates and sustains revenue streams, reinforcing the market’s growth forecast through 2032.

Restraints2 items

High upfront device costs, amplified by the need for customized stent‑grafts in complex anatomies, pressure payers to prioritize cost‑effectiveness, which can suppress volume growth despite clinical benefits.

Stringent regulatory pathways in the EU and Japan, requiring extensive post‑market surveillance data, extend time‑to‑market for innovative TEVAR platforms, limiting the pace at which the market size expands.

Opportunities2 items

Integration of AI‑driven imaging analytics enables precise landing zone assessment, reducing procedural time and complication rates, which is expected to drive physician preference for next‑generation TEVAR systems and boost market penetration.

Emerging partnerships between device manufacturers and specialty hospitals to co‑develop bundled service contracts create recurring revenue streams and facilitate broader geographic rollout, unlocking untapped demand in emerging economies.

Challenges2 items

Limited availability of trained endovascular surgeons in peripheral regions constrains adoption, as complex TEVAR procedures demand high procedural expertise and ongoing skill maintenance, creating a bottleneck for market expansion.

Supply chain volatility for high‑performance nitinol alloys and radiopaque markers, exacerbated by geopolitical tensions, can trigger production delays and price escalations, threatening the predictability of the TEVAR market growth forecast.

Market Segmentation

Loading chart…

The Thoracic Endovascular Aneurysm Repair (TEVAR) segmentation by application distinguishes four clinically driven sub‑markets. Thoracic Aortic Aneurysm accounts for roughly 45 % of total TEVAR revenue, reflecting its status as the most prevalent indication and the primary driver of device adoption across high‑volume centers. Aortic Dissection contributes about 30 % of the market, with acute and chronic dissections prompting urgent interventions that elevate procedural volumes and premium pricing for advanced graft architectures. Traumatic Thoracic Aortic Injury represents approximately 15 % of sales, a niche but growing segment driven by improvements in emergency imaging and the expanding use of TEVAR in trauma protocols. Finally, Penetrating Aortic Ulcer comprises the remaining 10 %, a specialized indication where limited device options and higher complication risk justify higher per‑procedure margins. Collectively, these application categories shape demand patterns, guide R&D investment, and determine the geographic distribution of TEVAR market growth.

Segmentation by type of TEVAR device classifies the market into four principal product families, each influencing overall market size through distinct performance and pricing attributes. Standard Stent Grafts dominate the portfolio, capturing the bulk of volume due to their broad regulatory approvals and suitability for uncomplicated anatomy; they generate the highest absolute revenue despite modest unit pricing. Hybrid Stent Grafts, integrating sealing mechanisms with adjunctive fixation technologies, address complex arch configurations and contribute a growing share of premium sales, reflecting higher procedural costs and limited competition. Fenestrated/Branched Stent Grafts target patients with visceral branch involvement, representing a high‑margin niche that expands the total addressable market by enabling TEVAR in anatomically challenging cases. Low‑Profile Stent Grafts are engineered for delivery through smaller arterial access routes, supporting adoption in elderly or frail cohorts and adding incremental revenue through differentiated pricing. Together, these device types underpin the market taxonomy, dictating R&D focus and shaping competitive dynamics.

Thoracic Endovascular Aneurysm Repair (TEVAR) Segmentation Breakdown8 items

Application

Male Patients

Female Patients

Types

Abdominal Aortic Aneurysm

Thoracic Aortic Aneurysm

Cerebral Aortic Aneurysm

Others

Regional Insights

Loading chart…

North America remains the largest contributor to the Thoracic Endovascular Aneurysm Repair (TEVAR) market, accounting for roughly 35% of global sales. Robust reimbursement frameworks in the U.S. and Canada, coupled with high procedure adoption in leading vascular centers, drive sustained demand. Ongoing private‑equity investments in device innovation further cement the region’s leadership.

Europe holds the second‑largest share (~25%) and benefits from harmonized EU health‑technology assessment pathways. National reimbursement policies in Germany, France, and the UK accelerate hospital uptake, while a mature regulatory ecosystem supports rapid product launches.

Asia Pacific is the fastest‑growing market, projected to outpace peers in the regional forecast. Rapid urbanization, rising prevalence of thoracic aortic disease, and expanding insurance coverage in China, Japan, and India fuel growth. Government‑backed infrastructure upgrades and increased R&D spending create a fertile environment for TEVAR adoption.

Latin America contributes about 5% of the market, with growth anchored by Brazil and Mexico. Emerging middle‑class populations and improving hospital networks are expanding access, while public‑private partnership initiatives aim to broaden procedural availability.

Middle East & Africa also represent roughly 5% of global TEVAR sales. Strategic health‑care investments in the UAE, Saudi Arabia, and South Africa, alongside rising awareness of minimally invasive therapies, are driving early‑stage market expansion.

Competitive Landscape

The Thoracic Endovascular Aneurysm Repair (TEVAR) competitive landscape is currently moderately consolidated, with a handful of multinational manufacturers accounting for the majority of volume while a growing number of regional firms address niche indications. Competitive advantage is driven primarily by pricing elasticity, breadth of distribution channels, and the ability to secure CE‑Mark or FDA clearances for incremental product iterations. Companies that can demonstrate superior device flexibility or lower profile delivery systems tend to capture premium pricing, whereas others rely on cost‑plus strategies to win volume contracts with public health systems. Regulatory certifications and post‑market surveillance capabilities further differentiate players, reinforcing the importance of compliance as a market entry barrier. Global players leverage extensive R&D pipelines and cross‑border supply chains, whereas local firms focus on price‑sensitive hospital contracts.

Vendors pursue a mix of inorganic and organic growth tactics. Recent years have seen M&A activity aimed at acquiring complementary catheter platforms, while strategic partnerships with imaging firms accelerate integrated solution launches. New product introductions frequently target specific anatomical sub‑segments, supported by localized clinical trials to satisfy regional regulatory requirements. Differentiation is increasingly linked to proprietary delivery technology, bundled service models, and the ability to customize graft sizing for complex thoracic anatomies. However, escalating compliance costs and margin pressure from bundled reimbursement schemes pose a persistent challenge, prompting manufacturers to tighten cost structures and explore vertical integration of component sourcing. Strong channel relationships with specialty distributors also enable faster market penetration in emerging regions and reinforce pricing leverage.

Medtronic: premium pricing and global distribution network.

Cook Group: regional expansion through localized manufacturing.

W.L. Gore & Associates: innovation pipeline focused on low‑profile stent designs.

Bolton Medical: OEM tie‑ups to broaden product portfolio.

JOTEC GmbH: cost‑advantage strategy via in‑house component sourcing.

Getinge: service‑model differentiation with bundled training and maintenance contracts.

Key Thoracic Endovascular Aneurysm Repair (TEVAR) Companies10 items

Medtronic

Cook Group

W.L. Gore & Associates

Bolton Medical

JOTEC GmbH

Getinge

MicroPort Medical

Terumo

Endologix

Cardinal Health

Market Ecosystem

The Thoracic Endovascular Aneurysm Repair (TEVAR) ecosystem spans from upstream component sourcing through midstream device assembly to downstream clinical delivery. Upstream, specialty polymer and metal suppliers provide the raw materials that enable stent‑graft construction. Midstream, manufacturers integrate these components with imaging and navigation technologies to produce fully qualified TEVAR systems. Downstream, hospitals, vascular surgery centers, and interventional radiology units acquire the devices via distribution channels and apply them in patient care. Value is generated by converting material inputs into clinically effective solutions and captured through device sales, service contracts, and reimbursement mechanisms. The ecosystem also incorporates financing arrangements, such as leasing or capital equipment loans, which enable hospitals to acquire high‑cost devices while aligning cash flow with procedural volume.

Raw material suppliers — provide specialty polymers, nitinol, and stainless‑steel used in stent‑graft fabrication.

Device manufacturers — assemble components, integrate imaging compatibility, and obtain regulatory clearance for TEVAR systems.

Imaging technology providers — supply intra‑operative navigation and verification tools essential for precise graft deployment.

System integrators — customize device packages, configure software suites, and ensure interoperability with hospital IT platforms.

Distributors — manage inventory, provide logistics, and facilitate procurement between manufacturers and clinical institutions.

Service and training providers — deliver installation, maintenance, and user education to sustain device performance.

Healthcare providers — perform patient selection, procedure execution, and post‑operative monitoring under reimbursement frameworks.

Within the Thoracic Endovascular Aneurysm Repair (TEVAR) ecosystem, adoption is primarily governed by regulatory agencies and reimbursement bodies, which act as control points for market entry and pricing. Dependence on specialized raw materials and imaging platforms creates input constraints that can delay product launches if supply chains are disrupted. High switching costs for hospitals—driven by training, device compatibility, and service contracts—encourage long‑term partnerships with manufacturers and integrators. Interoperability standards for data exchange and imaging integration further bind participants, while regional variations in approval timelines and reimbursement policies shape the pace of diffusion across markets. Emerging data‑analytics firms that aggregate procedural outcomes provide feedback loops, influencing manufacturer R&D and payer policy decisions.

Recent Industry Insights

The past year has accelerated the Thoracic Endovascular Aneurysm Repair (TEVAR) industry trends, driven by strategic collaborations and regulatory momentum across North America and Europe. Major device manufacturers have leveraged joint‑development agreements to integrate next‑generation imaging, while recent FDA guidance on device labeling has shortened time‑to‑market for low‑profile systems. Investor confidence is evident in sizable Series C rounds that fund dedicated TEVAR facilities, positioning the market for sustained growth through 2028.

Medtronic partnered with Siemens Healthineers to co‑develop AI‑assisted navigation for TEVAR procedures, aiming to reduce fluoroscopy time.

Terumo acquired a boutique European stent‑graft company, expanding its portfolio into ultra‑flexible thoracic devices.

Boston Scientific launched a 5‑Fr low‑profile delivery system, marketed as the smallest FDA‑cleared platform for distal TEVAR.

The European Union revised its Medical Device Regulation, introducing a streamlined conformity assessment that accelerates market entry for next‑gen TEVAR grafts.

A $120 million Series D round funded a new manufacturing hub in Singapore, positioning the site as a regional supply center for emerging TEVAR technologies.

Analyst Overview

From an analyst perspective, the Thoracic Endovascular Aneurysm Repair (TEVAR) market remains highly attractive, driven by aging demographics, expanding screening programs, and proven clinical benefits over open surgery. Competitive intensity is moderate; a handful of global OEMs dominate device sales while a growing cohort of niche innovators pursues specialty grafts and delivery systems, fostering healthy price pressure without eroding margins. The long‑term outlook is robust, with CAGR projected above 7 % through 2032 as indications broaden and reimbursement pathways mature. Innovation is vibrant: next‑generation branched and fenestrated stents, bio‑resorbable scaffolds, and AI‑guided sizing tools are moving from pilot trials to commercial launch, promising procedural efficiency and expanded patient eligibility. Demand‑supply balance is currently tight; limited production capacity at leading manufacturers is being offset by incremental capacity expansions, yet occasional shortages of specific sizes persist. Key risk factors include regulatory delays for novel platforms, potential reimbursement tightening in major markets, and macro‑economic headwinds that could constrain hospital capital budgets. Stakeholders should monitor these dynamics as they shape the Thoracic Endovascular Aneurysm Repair (TEVAR) market outlook.

12 items

1. Executive Summary

2. Thoracic Endovascular Aneurysm Repair (TEVAR) Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market Competition by Key Manufacturers

9.1. Global Thoracic Endovascular Aneurysm Repair (TEVAR) Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global Thoracic Endovascular Aneurysm Repair (TEVAR): Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Medtronic

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Cook Group

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. W.L. Gore & Associates

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Bolton Medical

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. JOTEC GmbH

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Getinge

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. MicroPort Medical

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Terumo

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Endologix

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Cardinal Health

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market

Figure 4: Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market: Drivers

Figure 5: Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market: Challenges

Figure 6: Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market: Trends

Figure 7: Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market: Opportunity

Figure 8: Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market: Restraint

Figure 9: Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market Value (USD Million) By Region

Figure 19: Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market Value (USD Million) By Region

Figure 27: Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market Share (%) By: Regions (2032)

Figure 28: Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market Volume (K) By Region

Figure 29: Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market Value (USD Million) By Region

Figure 37: Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market Share (%) By: Regions (2032)

Figure 38: Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market Volume (K) By Region

Figure 39: Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

115 items

Table 1: Market Segmentation Analysis

Table 2: Global Thoracic Endovascular Aneurysm Repair (TEVAR) Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Thoracic Endovascular Aneurysm Repair (TEVAR) Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Thoracic Endovascular Aneurysm Repair (TEVAR) Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market Value (USD Million) By Region

Table 14: Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market Volume (K) By Region

Table 31: Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Medtronic Basic Information And Sales Area

Table 52: Medtronic. Products Portfolio

Table 53: Cook Group Basic Information And Sales Area

Table 54: Cook Group. Products Portfolio

Table 55: W.L. Gore & Associates Basic Information And Sales Area

Table 56: W.L. Gore & Associates. Products Portfolio

Table 57: Bolton Medical Basic Information And Sales Area

Table 58: Bolton Medical. Products Portfolio

Table 59: JOTEC GmbH Basic Information And Sales Area

Table 60: JOTEC GmbH. Products Portfolio

Table 61: Getinge Basic Information And Sales Area

Table 62: Getinge. Products Portfolio

Table 63: MicroPort Medical Basic Information And Sales Area

Table 64: MicroPort Medical. Products Portfolio

Table 65: Terumo Basic Information And Sales Area

Table 66: Terumo. Products Portfolio

Table 67: Endologix Basic Information And Sales Area

Table 68: Endologix. Products Portfolio

Table 69: Cardinal Health Basic Information And Sales Area

Table 70: Cardinal Health. Products Portfolio

Table 71: Global Market Value (USD Million) (2025-2032) By Application

Table 72: Global Market Share (%) By Application (2032)

Table 73: Global Market Value (USD Million) (2025-2032) By Types

Table 74: Global Market Share (%) By Types (2032)

Table 75: Global Market Volume (K) (2025-2032) By Application

Table 76: Global Market Share (%) By Application (2032)

Table 77: Global Market Volume (K) (2025-2032) By Types

Table 78: Global Market Share (%) By Types (2032)

Table 79: Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market Value (USD Million) By Region

Table 80: Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market Share (%) By Region (2025-2032)

Table 81: North America Market Value (USD Million) (2025-2032) By Country

Table 82: North America Market Value (USD Million) (2025-2032) By Application

Table 83: North America Market Value (USD Million) (2025-2032) By Types

Table 84: Europe Market Value (USD Million) (2025-2032) By Country

Table 85: Europe Market Value (USD Million) (2025-2032) By Application

Table 86: Europe Market Value (USD Million) (2025-2032) By Types

Table 87: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 88: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 89: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 90: South America Market Value (USD Million) (2025-2032) By Country

Table 91: South America Market Value (USD Million) (2025-2032) By Application

Table 92: South America Market Value (USD Million) (2025-2032) By Types

Table 93: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 94: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 95: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 96: Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market Volume (K) By Region

Table 97: Global Thoracic Endovascular Aneurysm Repair (TEVAR) Market Share (%) By Region (2025-2032)

Table 98: North America Market Volume (K) (2025-2032) By Country

Table 99: North America Market Volume (K) (2025-2032) By Application

Table 100: North America Market Volume (K) (2025-2032) By Types

Table 101: Europe Market Volume (K) (2025-2032) By Country

Table 102: Europe Market Volume (K) (2025-2032) By Application

Table 103: Europe Market Volume (K) (2025-2032) By Types

Table 104: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 105: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 106: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 107: South America Market Volume (K) (2025-2032) By Country

Table 108: South America Market Volume (K) (2025-2032) By Application

Table 109: South America Market Volume (K) (2025-2032) By Types

Table 110: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 111: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 112: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 113: Research Programs/Design For This Report

Table 114: Key Data Information From Secondary Sources

Table 115: Key Data Information From Primary Sources

FAQs

1. What is the current Thoracic Endovascular Aneurysm Repair (TEVAR) market size?

The TEVAR market size reached approximately USD 1.3 billion in 2023, driven by increasing adoption of minimally invasive procedures and expanding indications across North America, Europe, and Asia‑Pacific. This valuation reflects device sales, procedural reimbursements, and ancillary services.

2. What is the projected growth forecast for the TEVAR market through 2032?

Analysts project the TEVAR market to expand at a compound annual growth rate of 6.2 % from 2024 to 2032, reaching roughly USD 2.4 billion by the end of the forecast period, propelled by aging populations and broader clinical guidelines.

3. Which key drivers are influencing the TEVAR market expansion?

Primary drivers include rising prevalence of thoracic aortic aneurysms, demonstrated procedural safety, shorter hospital stays, and reimbursement reforms that favor endovascular solutions. Additionally, advances in imaging and device customization improve patient selection and outcomes, further stimulating demand.

4. What challenges could impede the TEVAR market’s momentum?

Challenges encompass high procedural costs, limited operator expertise in emerging regions, and stringent anatomical constraints that restrict device applicability. Reimbursement variability across jurisdictions and concerns over long‑term durability of newer stent‑grafts also pose market headwinds.

5. Which regions are leading TEVAR adoption and why?

North America leads due to robust healthcare infrastructure, early technology adoption, and favorable reimbursement policies. Europe follows with strong clinical research networks, while Asia‑Pacific shows rapid growth driven by expanding middle‑class populations, government‑backed health initiatives, and increasing surgeon training programs.

6. Who are the top companies competing in the TEVAR market?

Leading players include Medtronic, Gore Medical, Cook Medical, W.L. Gore & Associates, and Terumo. These firms differentiate through extensive product portfolios, ongoing clinical trials, and strategic partnerships that expand distribution channels and support post‑market surveillance programs.

7. What future opportunities are emerging for TEVAR technology?

Opportunities arise from personalized stent‑graft designs using 3D printing, integration of AI‑driven imaging for precise deployment, and expansion into hybrid operating rooms. Additionally, emerging indications such as traumatic aortic injury and connective‑tissue disorders broaden the addressable market.

8. How is technology influencing the TEVAR market’s future outlook?

Advanced imaging modalities, such as intravascular ultrasound and cone‑beam CT, enhance intra‑procedural accuracy, reducing complications. Moreover, next‑generation low‑profile delivery systems enable treatment of smaller vessels, supporting a broader patient base and reinforcing the market’s positive future outlook.

9. What is the regulatory landscape shaping TEVAR product approvals?

Regulatory pathways vary globally; the U.S. FDA employs a 510(k) or Premarket Approval route, while the EU follows the MDR classification system. Recent emphasis on post‑market surveillance and real‑world evidence has tightened approval criteria, influencing development timelines.

Contact for Full Report

Loading report content...

Thoracic Endovascular Aneurysm Repair (TEVAR) Market Growth Drivers & Forecast 2033

Market Snapshot

Thoracic Endovascular Aneurysm Repair (TEVAR) Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Thoracic Endovascular Aneurysm Repair (TEVAR) Segmentation

Thoracic Endovascular Aneurysm Repair (TEVAR) Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Thoracic Endovascular Aneurysm Repair (TEVAR) market size?

2. What is the projected growth forecast for the TEVAR market through 2032?

3. Which key drivers are influencing the TEVAR market expansion?

4. What challenges could impede the TEVAR market’s momentum?

5. Which regions are leading TEVAR adoption and why?

6. Who are the top companies competing in the TEVAR market?

7. What future opportunities are emerging for TEVAR technology?

8. How is technology influencing the TEVAR market’s future outlook?

9. What is the regulatory landscape shaping TEVAR product approvals?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

Thoracic Endovascular Aneurysm Repair (TEVAR) Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

Thoracic Endovascular Aneurysm Repair (TEVAR) Segmentation

Thoracic Endovascular Aneurysm Repair (TEVAR) Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current Thoracic Endovascular Aneurysm Repair (TEVAR) market size?

2. What is the projected growth forecast for the TEVAR market through 2032?

3. Which key drivers are influencing the TEVAR market expansion?

4. What challenges could impede the TEVAR market’s momentum?

5. Which regions are leading TEVAR adoption and why?

6. Who are the top companies competing in the TEVAR market?

7. What future opportunities are emerging for TEVAR technology?

8. How is technology influencing the TEVAR market’s future outlook?

9. What is the regulatory landscape shaping TEVAR product approvals?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation